Ondo InsurTech PLC Director/PDMR Share Dealing
11 Mars 2025 - 5:56PM
RNS Regulatory News
RNS Number : 2525A
Ondo InsurTech PLC
11 March 2025
11 March 2025
Ondo Insurtech
Plc
("Ondo" or the
"Company")
Director/PDMR Share
dealing
Ondo Insurtech (LSE: ONDO),
a leading company in claims prevention technology
for home insurers, announces that Charlene Hill, spouse of
Chief Executive, Craig Foster, exercised warrants over 125,000
ordinary shares of 5 pence each in the capital of the Company
("Ordinary Shares") at an exercise price of 25 pence per warrant on
7 March 2025 ("New Ordinary Shares"). On the same day, Charlene
Hill also sold 105,000 Ordinary
shares (to cover taxes and exercise
costs) at a price of 35.8 pence, having previously
held 250,000 Ordinary Shares. Following the warrant exercise and share sale
Charlene Hill is now interested in 270,000
Ordinary Shares, which represents
approximately 0.21% of the issued share capital of the Company.
The New Ordinary Shares have been
admitted to listing on the Equity Shares
(Transition) category of the Official List of the Financial Conduct
Authority and to trading on the London Stock Exchange's main market
for listed securities under the Company's block
listing.
Charlene Hill's interests in the
Company were acquired through her participation in the fundraising
undertaken by the Company in March 2022 in conjunction with its
acquisition of the entire issued share capital of LeakBot Limited
by way of a reverse takeover. At that time Charlene Hill was not a
person closely associated ("PCA") with Craig Foster for UK MAR
purposes. Following their marriage in August 2023, Charlene Hill
has been a PCA with Craig Foster and accordingly, her interests
should have been incorporated with and reflected when reporting the
interests of Craig Foster, but this disclosure was not made in
error.
Craig Foster's interests in the
Company as at 1 August 2023 were as set out below:
|
Shareholding at August
2023
|
% of issued share
capital
|
Number of
warrants
|
Number of share
options
|
Craig Foster
|
1,779,567
|
2.23%
|
889,783
|
2,320,000
|
Charlene Hill
|
250,000
|
0.32%
|
125,000
|
-
|
Total
|
2,029,567
|
2.55%
|
1,014,783
|
2,320,000
|
Following the share sale and
exercise of
warrants described above, as at 11 March 2025,
Craig Foster's beneficial interests in the Company
are now:
|
Shareholding(1)
|
% of issued share
capital
|
Number of
warrants
|
Number of share
options
|
Craig Foster
|
2,448,844
|
1.90%
|
-
|
3,920,000
|
(1) 270,000 Ordinary
Shares are held by Craig Foster's wife
Enquiries
Ondo InsurTech Plc
|
Craig Foster, CEO
Kevin Withington, CFO
|
+44 (0) 800 783 9866
|
Dowgate Capital Ltd
(Broker & Financial
Advisor)
|
Russell Cook
Nick Chambers
Charlie Hall
|
+44 (0) 20 3903 7715
|
Cassiopeia Services Ltd
(PR & Investor
Relations)
|
Stefania Barbaglio
|
+44 (0) 7949 690338
|
The information set out below is
provided in accordance with the requirements of Article 19 of the
Market Abuse Regulations.
1.
|
Details of PDMR / person closely
associated with them ("PCA").
|
a)
|
Name
|
Charlene Hill
|
2
|
Reason for
notification
|
|
a)
|
Position/Status
|
PCA - spouse of Craig Foster, Chief
Executive and PDMR
|
b)
|
Initial Notification /
amendment
|
Initial Notification
|
3
|
Details of the issuer,
emission allowance market participant, auction platform,
auctioneer
|
|
or auction
monitor
|
|
a)
|
Name
|
Ondo InsurTech Plc
|
b)
|
LEI
|
2138005Y5QBJQMOOI719
|
4
|
Details of the
transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and
(iv) each place where transactions have been
conducted
|
a)
|
Description of the
financial
|
Ordinary shares of 5 pence
each
|
|
instrument, type of
instrument
|
|
|
Identification code
|
ISIN: GB00BNVVGD77
|
b)
|
Nature of transaction
|
Exercise of warrants for ordinary
shares
|
c)
|
Price(s) and volume(s)
|
Exercise of warrants over 125,000
Ordinary Shares at an exercise price of 25 pence per
warrant
|
d)
|
Aggregated information
|
n/a
|
e)
|
Date of transaction
|
7 March 2025
|
f)
|
Place of transaction
|
Outside of a trading
venue
|
1.
|
Details of PDMR / person closely
associated with them ("PCA").
|
a)
|
Name
|
Charlene Hill
|
2
|
Reason for
notification
|
|
a)
|
Position/Status
|
PCA - spouse of Craig Foster, Chief
Executive and PDMR
|
b)
|
Initial Notification /
amendment
|
Initial Notification
|
3
|
Details of the issuer,
emission allowance market participant, auction platform,
auctioneer
|
|
or auction
monitor
|
|
a)
|
Name
|
Ondo InsurTech Plc
|
b)
|
LEI
|
2138005Y5QBJQMOOI719
|
4
|
Details of the
transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and
(iv) each place where transactions have been
conducted
|
a)
|
Description of the
financial
|
Ordinary shares of 5 pence
each
|
|
instrument, type of
instrument
|
|
|
Identification code
|
ISIN: GB00BNVVGD77
|
b)
|
Nature of transaction
|
Sale of Ordinary Shares
|
c)
|
Price(s) and volume(s)
|
Price
|
Volumes
|
35.8p
|
105,000
|
|
|
|
d)
|
Aggregated information
|
n/a
|
e)
|
Date of transaction
|
7 March 2025
|
f)
|
Place of transaction
|
London Stock Exchange, Main Market
(XLON)
|
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
DSHQFLFFEXLEBBX
Ondo Insurtech (LSE:ONDO)
Graphique Historique de l'Action
De Fév 2025 à Mar 2025
Ondo Insurtech (LSE:ONDO)
Graphique Historique de l'Action
De Mar 2024 à Mar 2025